A multi-center, randomized, double-blind, placebo-controlled, parallel group, repeated-dose study to evaluate the efficacy, safety, tolerability and pharmacokinetics of three different dosing regimens of inhaled indacaterol maleate in patients with persistent asthma

Phase 2

Completed

• Conditions: airway infection; Asthma; 10024970

• Registration Number: NL-OMON34929
• Lead Sponsor: ovartis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 10

Inclusion Criteria

Patients with persistent asthma
18 years and older

Exclusion Criteria

COPD diagnosed

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Effect of three different indaceterol dosing regimens on trough FEV1 after<br /><br>2-weeks of treatments</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Safety, pharmacokinetics</p><br>